[Table/Fig-5]:

Comparison with cancer detection rates of TRUS biopsy reported worldwide [8,11,12,15–33].

Author	Country	Number of patients (n)	Cancer detection Rate (Percent)
			Overall	PSA <4	PSA 4-10	PSA 10-20	PSA 20-50	PSA 50-100	PSA >100
Janbaziroudsari et al., [16]	Iran	139	32.4	8.9	13.3	77.8
Ghafoori et al., [8]	Iran	330	35	-	-	-	-	-	-
Teoh et al., [22]	Hong Kong	2606	27.6	8.6*	13.4*	21.8*	41.7*	85.2*
				12.4†	30.2†	52.7†	80.6†	96.4†
Lee et al., [20]	Singapore	804	35.1	9.5	20.9	38.4	72.3
Sarikaya et al., [29]	Turkey	835	17.8	-	12.4	-	-	-	-
Miyoshi et al., [23]	Japan	195	-	-	33.8		-	-	-
Teo et al., [21]	Singapore	120	22.5	14.9		50
Vida et al., [25]	Romania	1525	69.77	-	-	-	-	-	-
Agnihotri et al., [11]	India	875	57.5	20†	15.2*	24*	62.6*
					59.57†	68.3†	95.2†
Ojewola et al., [30]	Nigeria	168	44	17.4	28.9	37	55.8	85.7
Leibovici et al., [17]	Israel	155	29	-	-	-	-	-	-
Lodeta et al., [31]	Croatia	897	38.9	-	-	-	-	-	-
Na R et al., [19]	China	1650	47	-	14.8	27.4	75.8
					(For PSA <10)
Narayanaswamy et al., [18]	Kuwait	153	27.4	-	11.8	20.5	47.1		83.3
Sinha et al., [12]	India	119	24.37	-	7.14	6.67	52.17
Kahraman et al., [32]	Turkey	76	16	-	-	-	-	-	-
Rodriguez et al., [26]	Spain	6000	39.1	30.4	29.6	44	62.03	92.9
Imazu et al., [24]	Japan	978	54.3	32.1	45.7	79.5
Abril et al., [33]	Mexico	2016	37	-	-	-	-	-	-
Yu et al., [15]	Taiwan	185	14.6	-	-	-	-	-	-
Orozco et al., [28]	US	62537	38.3	16.2*	25.3*	31.7*	47.4*
				18.8†	38.7†	52.4†	76.7†
Gonzalez et al., [27]	Spain	115	24.3	4.76	5.12	48
Our Study	India	235	25.53	-	5.95	13.16	32.26	100	100

* Normal DRE; ^† Abnormal DRE